CLINICAL MANAGEMENT PROTOCOL

Centre considering removing plasma therapy from COVID-19 clinical management protocol

The decision may disrupt ongoing plasma therapy programmes in the country. Several states and hospitals have not only backed the therapy, b...

Remdesivir use may continue in India as few options in sight

Doctors say they find Remdesivir helps reduce viral load in moderate cases. Some, however, question its effectiveness and price. They have ...

COVID-19: Central teams sent to Kerala, Karnataka, Rajasthan, Chhattisgarh, WB

The Union Health Ministry on Friday said these teams will support the state towards strengthening containment, surveillance, testing, infec...

Ayurveda, Yoga to be used to combat COVID-19 as Health Minister releases protocol

"This protocol dealing with preventive and prophylactic measures is a significant step not only in management of COVID-19 but also in makin...

Ayush Ministry to take up clinical study on potential of Vasa, Guduchi for management of COVID-19

This will be a randomized, open label three armed study, and will be conducted at the All India Institute of Ayurveda (AIIA), New Delhi, in...

Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine

The DCGI has asked the company certain conditions like taking extra care during screening, providing additional information in informed con...

Health ministry asks DGCI to ensure equitable distribution of Remdesivir, Tocilizumab drugs

The ministry has shot off a letter to the Drugs Controller General of India (DCGI), asking it to ascertain how many states and Union territ...

Health ministry decides against including Itolizumab in clinical management protocols for COVID-19

The permission to market the drug was granted for the treatment of cytokine release syndrome in 'moderate' to 'severe' Acute Respiratory Di...

Glenmark defends price of its COVID-19 drug favipiravir version after DCGI sends notice

“Compared to other therapies approved for emergency use in COVID-19, FabiFlu is much more economical and an effective treatment option,” th...

'Indiscriminate use of remdesivir, tocilizumab on COVID patients can cause more harm than good'

The ICMR strongly recommended that the focus of clinical management should continue to remain on oxygen therapy, steroids which are widely ...

Doctors advised to use Remdesivir on COVID-19 patients strictly under laid-down protocol

To prevent black-marketing and overcharging of the drug, India's drug regulator Drugs Controller General of India (DCGI) has asked manufact...

Bharat Biotech’s Covid vaccine gets DCGI nod for clinical trials

The SARS-CoV-2 strain was isolated in NIV and transferred to Bharat Biotech, which has developed the indigenous, inactivated vaccine at its...

Health Ministry adds steroid dexamethasone in COVID-19 treatment protocol

The updated protocol includes the advice to use dexamethasone as an alternative choice to methylprednisolone for managing moderate to sever...

WHO's decision to resume HCQ clinical trial a step in right direction, say experts

The global heath body had earlier suspended the hydroxychloroquine (HCQ) arm of the clinical trials of experimental COVID-19 drugs over saf...

Empowered group working on protocol for non-Covid-19 care

Nudged by the empowered group, Indian Council of Medical Research (ICMR) and All India Institute of Medical Sciences (AIIMS) have begun hol...

Glenmark initiates Phase 3 clinical trials on Favipiravir to check efficacy on COVID-19 patients

The Mumbai-based company had received approval from Drug Controller General of India (DCGI) last month to conduct clinical trials of Favipi...

Demand surge for 'game changer' COVID-19 drug hydroxychloroquine despite lack of clinical evidence

Though there have been no large-scale clinical trials of the drug's efficacy in treating coronavirus, chemists all over say they are facing...